The Science of CRVO via Facebook:
Retinal vein occlusion (RVO) is significantly associated with stroke development, according to a recent study. Although the investigators adjusted for potential confounders, they acknowledge that the findings are still limited. Tyler Hyungtaek Rim, MD, MBA, from Yonsei University College of Medicine in Seoul, South Korea, and colleagues published the results of their nationwide, population-based, 9-year longitudinal study online February 25 in Ophthalmology. They examined 6105 sociodemographically matched subjects who were extracted from a national database of 1,025,340 patients. - 1 year ago

The Science of CRVO via Facebook:
Adding topical squalamine to ranibizumab improves visual acuity significantly more than ranibizumab alone in patients with retinal vein occlusion, a small trial shows. "At week 10, I was already seeing better results than most trials at 1 year," said John Wroblewski, MD, from Cumberland Valley Retina Consultants, in Hagerstown, Maryland. Dr. Wroblewski presented the study results here at the American Society of Retina Specialists (ASRS) 2016 Annual Meeting. - 1 year ago

The Science of CRVO via Facebook:
“Retinal artery occlusion is a medical emergency. Loss of vision may be permanent if blood flow is not restored within 24 hours. Treatment aims to increase blood flow to the retina, but treatment options are limited, and none are very effective. They include injecting a clot-busting drug into the retinal artery and using a blood vessel-widening medication to improve blood flow.” - 1 year ago

The Science of CRVO via Facebook:
Researchers from the Retina Macula Institute in Torrance, CA published a paper on their research to test the efficacy of the intravitreal dexamethasone (DEX) implant in patients with retinal vein occlusions (RVOs) who have failed multiple anti-vascular endothelial growth factor (anti-VEGF) treatments. The researchers concluded that DEX should be considered as a treatment option in patients with RVOs who have failed anti-VEGF therapy as the results of this study demonstrated an improvement in retinal morphology and macular function. - 1 year ago

The Science of CRVO via Facebook:
Patients with psoriasis may have a higher risk of developing retinal vein occlusion, according to a study. The retrospective population-based cohort study evaluated the risk and incidence of developing RVO in 30,198 psoriasis patients compared with 30,198 control subjects without psoriasis from the Taiwan National Health Insurance Research Database. - 1 year ago

The Science of CRVO via Facebook:
Two treatment options, anti-vascular endothelial growth factors (anti-VEGFs) and corticosteroids, with different mechanisms of action are available for the treatment of macular edema secondary to Central Retinal Vein Occlusion (CRVO). The study, COMRADE-C, is the first head-to-head study to investigate the clinical efficacy and safety of the European labels of ranibizumab (anti-VEGF) versus dexamethasone intravitreal implant (corticosteroid) in patients with CRVO over six months. - 1 year ago

The Science of CRVO via Facebook:
#Didyouknow that evidence from NEI-supported investigators demonstrates that omega-3 fatty acids may prevent eye diseases caused by proliferative retinopathies and keep our eyes healthy? Cold-water fish like tuna, salmon, and mackerel are plentiful in fatty acids like DHA and EPA. Watch #U2's The Edge to learn more about disease preventing foods and to learn about the work of the Angiogenesis Foundation at bit.ly/EatToBeat - 1 year ago

The Science of CRVO via Facebook:
After an initial trial period of one month, with no eyes showing signs of toxicity, it has been determined that Ziv-aflibercept may be a safe, low-cost alternate therapy for macular diseases. Particularly in developing countries and countries where intravitreal aflibercept is not available. http://ow.ly/4n4HHw - 1 year ago

The Science of CRVO via Facebook:
A recent study was conducted to see whether obstructive sleep apnea is common among patients with branch retinal vein occlusion and the results were quite interesting. The study found that obstructive sleep apnea “could be an additional risk factor in the pathogenesis of BRVO or at least a frequently associated condition that could function as a triggering factor.” http://ow.ly/10y01I - 1 year ago

The Science of CRVO via Facebook:
A study found that “individualized dosing of ranibizumab guided by stabilization criteria significantly improved best corrected visual acuity in patients with macular edema secondary to central retinal vein occlusion.” A major result was that patients who had CRVO for more than nine months had an average BCVA gain of 10.9 letters. http://ow.ly/102QZc - 1 year ago

The Science of CRVO via Facebook:
The below image is from this year’s award-winning series of images from the Wellcome Image Awards. It may look like something from a science fiction film, but the image is actually of an eye suffering from Central Retinal Vein Occlusion (CRVO). To see more fascinating medical images, visit: http://ow.ly/ZrUrC Photo Credit: Kim Baxter, Cambridge University Hospitals NHS Foundation Trust - 2 years ago

The Science of CRVO via Twitter:
Our new educational website http://t.co/0pYNsVK4YA will be launching soon. Stay tuned! - 4 years ago

The Science of CRVO via Twitter:
Launching soon: we will disseminate knowledge about antiangiogenic treatments for CRVO in order to improve patient outcomes! #retina #vision - 4 years ago